Psyence Biomedical Ltd. Warrant
Psyence Biomedical Ltd. Warrant
Your view on PBMWW
Overview
What the company does, where it operates, and who runs it.
About Psyence Biomedical Ltd. Warrant
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Jody Aufrichtig
- Headquarters
- 121 Richmond Street West, Toronto, ON, CA
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Jody Aufrichtig
- Headquarters
- 121 Richmond Street West, Toronto, ON, CA
Psyence Biomedical Ltd. focuses on developing psychedelic medications derived from botanical psilocybin. The company is also investigating the use of natural psilocybin to alleviate adjustment disorder in patients with incurable cancer who are undergoing palliative care. Its primary product candidate, PEX010, is a capsule containing naturally sourced psilocybin, which is currently undergoing a Phase IIb clinical study. PEX010 aims to treat anxiety, depression, and related conditions such as post-traumatic stress disorder, stress, grief, and adjustment disorder, especially in a palliative care context. Psyence Biomedical has partnered with iNGENu Pty Ltd to conduct a Phase IIb clinical trial, examining PEX010's efficacy in psilocybin-assisted psychotherapy for adjustment disorder caused by incurable cancer. Headquartered in Toronto, Canada, the company operates as a subsidiary of Psyence Group Inc.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Psyence Biomedical Ltd. Warrant, and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Psyence Biomedical Ltd. Warrant. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Psyence Biomedical Ltd. Warrant. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Psyence Biomedical Ltd. Warrant. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Psyence Biomedical Ltd. Warrant. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Psyence Biomedical Ltd. Warrant valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Psyence Biomedical Ltd. Warrant, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Psyence Biomedical Ltd. Warrant executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Psyence Biomedical Ltd. Warrant. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Psyence Biomedical Ltd. Warrant. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Psyence Biomedical Ltd. Warrant. Press releases and market coverage, newest first.